Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression-Reference-Cited by-同舟云学术

Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

Published:2019-08 Issue:4 Volume:17 Page:e751-e758
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Di Maida Fabrizio,Mari Andrea,Scalici Gesolfo Cristina,Cangemi Antonina,Allegro Rosalinda,Sforza Simone,Cocci Andrea,Tellini Riccardo,Masieri Lorenzo,Russo Antonio,Carini Marco,Minervini Andrea^ORCID,Serretta Vincenzo^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. EAU guidelines on non-muscle invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013

2. Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group;Kamat;J Clin Oncol,2016

3. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non–muscle-invasive stage Ta–T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Guerin;Cambier;Eur Urol,2016

4. Clinical outcome in a contemporary series of restaged patients with cT1 bladder cancer;Dalbagni;Eur Urol,2009

5. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy;Shariat;Eur Urol,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence;Diagnostics;2023-10-13

2. Expression of epidermal growth factor receptor and human epidermal growth factor receptor 2 in urothelial bladder carcinoma in an Egyptian cohort: Clinical implication and prognostic significance;Urologia Journal;2023-01-20

3. Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer;Minerva Urology and Nephrology;2022-09

4. TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer;Cancer Reports;2021-06-07

5. Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics;Frontiers in Oncology;2021-05-27